|
Carnegie Mellon's leadership in the interdisciplinary research of science and
technology has laid the foundation for a new century of discovery.
Building on its core strengths, the university will expand its current areas
of comparative advantage in these biotechnology, life science and health policy
areas:
- Biomedical Engineering
- Computational Biology and Chemistry
- Drug Discovery
- Medical Robotics
- Nanotechnology
- Neuroscience
- Tissue Engineering
|
|
